Eldor R, Avraham N, Rosenberg O, Shpigelman M, et al. Erratum. Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titrati Diabetes Care 2025 Dec 3:dc26er02a. doi: 10.2337.
PMID: 41337783